News

Launch of the New European Bauhaus Prizes

Published on | 4 years ago

Programmes Missions New European Bauhaus Horizon Europe JRC Green Deal

Applications are now open for the first New European Bauhaus Prizes, launched by Commissioner Ferreira and Commissioner Gabriel during the New European Bauhaus Conference.

The New European Bauhaus Initiative has the ambition to make the Green Deal a cultural, human-centred and positive, tangible experience.

To accelerate the green transition, contribute to the recovery and ensure a better living together for all, we have to capitalise on the existing wealth of knowledge, experience and capacities as much as to call for new visions, ideas and solutions. The New European Bauhaus Prizes will encourage that.

The deadline for submission is 31 May 2021.

More information can be found here

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1728 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.